Brückner, L.; Reinshagen, A.; Hoang, N.A.; Höhn, A.K.; Lordick, F.; Bechmann, I.; Aktas, B.; Nel, I.; Kallendrusch, S.
FOXM1 Inhibition in Ovarian Cancer Tissue Cultures Affects Individual Treatment Susceptibility Ex Vivo. Cancers 2021, 13, 956.
https://doi.org/10.3390/cancers13050956
AMA Style
Brückner L, Reinshagen A, Hoang NA, Höhn AK, Lordick F, Bechmann I, Aktas B, Nel I, Kallendrusch S.
FOXM1 Inhibition in Ovarian Cancer Tissue Cultures Affects Individual Treatment Susceptibility Ex Vivo. Cancers. 2021; 13(5):956.
https://doi.org/10.3390/cancers13050956
Chicago/Turabian Style
Brückner, Luzie, Annika Reinshagen, Ngoc Anh Hoang, Anne Kathrin Höhn, Florian Lordick, Ingo Bechmann, Bahriye Aktas, Ivonne Nel, and Sonja Kallendrusch.
2021. "FOXM1 Inhibition in Ovarian Cancer Tissue Cultures Affects Individual Treatment Susceptibility Ex Vivo" Cancers 13, no. 5: 956.
https://doi.org/10.3390/cancers13050956
APA Style
Brückner, L., Reinshagen, A., Hoang, N. A., Höhn, A. K., Lordick, F., Bechmann, I., Aktas, B., Nel, I., & Kallendrusch, S.
(2021). FOXM1 Inhibition in Ovarian Cancer Tissue Cultures Affects Individual Treatment Susceptibility Ex Vivo. Cancers, 13(5), 956.
https://doi.org/10.3390/cancers13050956